M 335 (Olanzapine 7.5 mg)
Pill imprint M 335 has been identified as Olanzapine 7.5 mg.
Olanzapine is used in the treatment of bipolar disorder; agitated state; major depressive disorder; schizophrenia; insomnia (and more), and belongs to the drug class atypical antipsychotics. Risk cannot be ruled out during pregnancy. Olanzapine 7.5 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- M 335
- Strength:
- 7.5 mg
- Color:
- White
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Atypical antipsychotics
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC):
- 00378-5335
- Inactive Ingredients:
- lactose anhydrous
crospovidone
hypromelloses
magnesium stearate
microcrystalline cellulose
polyethylene glycol
polyvinyl alcohol
sodium lauryl sulfate
magnesium silicate
titanium dioxide
More about olanzapine
Consumer resources
- Olanzapine
- Olanzapine extended-release
- Olanzapine orally disintegrating tablets
- Olanzapine tablets
- Olanzapine injection
- More (2) »
- Other brands: Zyprexa, Zyprexa Zydis, Zyprexa Intramuscular, Zyprexa Relprevv
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
